Skip to main content
IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC).
Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey.
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.
Interleukin(IL)-1/IL-6-inhibitor-associated drug reaction with eosinophilia and systemic symptoms (DReSS) in systemic inflammatory illnesses.
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use.
Improving Access to Therapy for Patients With Inborn Errors of Immunity: A Call to Action.
Transition of Care in Inborn Errors of Immunity: Outcomes of a Single-Center Quality Improvement Initiative.
Similar response to omalizumab in children with allergic asthma from different racial backgrounds.
A Spot of Good News: Israeli Experience With SCID Newborn Screening.
Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data From the USIDNET Registry.